TAMMY GARDELL: Open Payments
NPI 1558517086 · SHIRLEY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 28 payments from 8 companies in 2025. Trend: 2023 $1,415 · 2024 $1,362 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $149 |
| Lilly USA, LLC | 5 | $107 |
| Novo Nordisk Inc | 4 | $76 |
| Ardelyx, Inc. | 4 | $73 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Abbott Laboratories | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: LINZESS, MOUNJARO, IBSRELA, Ozempic, GEMTESA, Wegovy, ZEPBOUND, UBRELVY.
Industry payments across MA — which companies pay providers there.
